NOS2 and colorectal carcinoma: These observations highlight the intrinsic heterogeneity in iNOS responsiveness among CRC subtypes, which may stem from underlying genetic and epigenetic differences that modulate key upstream regulatory pathways, particularly NF-κB and STAT1 signaling.